Price
Target price
€1.37
€1.37
-4.160%
-0.0604
-4.160%
€10.20
23.04.24 / Tradegate
WKN: A1C3EQ / Symbol: PACB / Name: PacBio / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pacific Biosciences of California Inc. Stock
Pacific Biosciences of California Inc. took a tumble today and lost -€0.060 (-4.160%).
Our community is currently high on Pacific Biosciences of California Inc. with 12 Buy predictions and 5 Sell predictions.
Based on the current price of 1.37 € the target price of 10 € shows a potential of 630.67% for Pacific Biosciences of California Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Pacific Biosciences of California Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Pacific Biosciences of California Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Pacific Biosciences of California Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Pacific Biosciences of California Inc. | -4.160% | -45.637% | -57.690% | -85.525% | -84.513% | -94.281% | -78.057% |
| MicroVision Inc | 0.260% | -6.877% | -16.403% | -25.857% | -47.773% | -87.943% | 40.469% |
| Fonar Corp. New | 0.650% | -3.125% | -24.020% | 7.639% | -12.429% | 4.730% | -9.240% |
| Fluidigm Corp. | 0.880% | -8.800% | -5.785% | 45.223% | 10.680% | -39.029% | - |
Comments
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Sanford C. Bernstein from $9.00 to $2.50. They now have an "outperform" rating on the stock.
Show more
Ratings data for PACB provided by MarketBeat
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Show more
Ratings data for PACB provided by MarketBeat
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $9.00 to $7.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PACB provided by MarketBeat
